newsfilter
← Latest News
GlobeNewswire·

Surface Oncology to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Rob Ross, M.D., chief ex